MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
van Kordelaar JM et al. | Interaction of contraceptive progestins and related compounds with the oestrogen receptor. Part II: Effect on (3H)oestradiol binding to the rat uterine receptor in vitro. | 1975 | Acta Endocrinol. | pmid:46681 |
Silfverstolpe G et al. | Lipid metabolic studies in oophorectomized women. Effects induced by the addition of norethisterone acetate to two different oestrogens on serum individual phospholipids and serum lecithin fatty acid composition. | 1981 | Acta Endocrinol. | pmid:7211107 |
KRAAY RJ and BRENNAN DM | Evaluation of chlormadinone acetate and other progestogens for foetal masculinization in rats. | 1963 | Acta Endocrinol. | pmid:14035354 |
Larsson-Cohn U et al. | Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens. | 1970 | Acta Endocrinol. | pmid:5468622 |
Zachmann M et al. | Influence of oestrogen in high and low doses on plasma steroid concentrations in girls with tall stature and Turner syndrome. | 1984 | Acta Endocrinol. | pmid:6741400 |
DESAULLES PA and KRAEHENBUEHL C | COMPARISON OF THE ANTI-FERTILITY AND SEX HORMONAL ACTIVITIES OF SEX HORMONES AND THEIR DERIVATIVES. | 1964 | Acta Endocrinol. | pmid:14225842 |
Bellmann O et al. | In vitro studies on enzymatic cleavage of steroid esters in the female organism. | 1976 | Acta Endocrinol. | pmid:130782 |
Hoppen HO and Hammann P | The influence of structural modification on progesterone and androgen receptor binding of norethisterone. Correlation with nuclear magnetic resonance signals. | 1987 | Acta Endocrinol. | pmid:3618086 |
Balogh A et al. | Effect of the norethisterone minipill on the plasma levels of biologically and immunologically active luteinizing hormone in women. | 1979 | Acta Endocrinol. | pmid:517047 |
Larsson-Cohn U et al. | Effects of continuous daily administration of 0.3 mg of norehtindrone on the plasma levels of progesterone and on the urinary excretion of pregnanediol and total oestrogens. | 1970 | Acta Endocrinol. | pmid:4195422 |